期刊文献+

卫生部全国细菌耐药监测网2010年女性尿标本细菌耐药监测 被引量:9

Ministry of Health National Antimicrobial Resistant Investigation Net 2010 annual report: Bacterial resistances monitor of women urine samples
下载PDF
导出
摘要 目的总结我国2010年临床女性患者尿标本来源细菌耐药状况。方法用常规方法,培养分离卫生部全国细菌耐药性监测网(Mohnarin)所属129家医院2010年度女性尿标本中的细菌,用自动化临床微生物测定方法、纸片法或E-test法,测定细菌药物敏感性,用WHONET 5.6软件进行分析。结果共分离细菌21904株。其中排在前5位的依次为大肠埃希菌(51.47%)、粪肠球菌(7.66%)、屎肠球菌(7.59%)、肺炎克雷伯杆菌(6.82%)及奇异变形杆菌(3.55%)。对大肠埃希菌耐药率较低的抗生素,依次为碳青霉烯类(≤1.5%)、磷霉素(2.4%)、哌拉西林/他唑巴坦(3.5%)、头孢哌酮/舒巴坦(4.7%)、阿米卡星(7.4%)、呋喃妥因(6.9%)、头孢西丁(12.6%)及阿莫西林/克拉维酸(21.1%)。对肠球菌耐药率较低的抗生素,依次为利奈唑胺(0)、糖肽类(0.4%~5.1%)、磷霉素(6.7%~17.2%)及呋喃妥因(6.6%~47.9%)。结论泌尿系统感染的主要致病菌仍为大肠埃希菌;但肠球菌的比例明显升高。 Objective To summarize bacterial resistance in the women clinical urine culture samples collected in 2010 from 129 hospitals of Ministry of Health Antibiotic Resistance Monitoring Network ( Mohnarin). Methods Conventional culture, automatic clinical microbiological system, disk diffusion and E - test methods were used for antibacterial activity of antimicrobial agents and resistances and sensitivity were calculated by using WHONET 5.6 software. Results A total of 21904 strains of bacteria were isolated, of which 51.47% of E. coli, Enterococcus faecalis ( 7.66% ), Enterococcus faecium ( 7.59% ), Klebsiella pneumonia (6. 82% ) and Proteus mirabilis (3.55%), respectively. The antimicro- bial agents with lower antibiotic resistance rates of E. coli were carbapen- ems ( ~〈 1.5%), fosfomycin ( 2. 4%), piperacillin / tazobactam (3.5%) , cefoperazone/sulbactam (4. 7% ) , amikacin (7.4%) , nitro- furantoin ( 6.9% ) , cefoxitin ( 12.6% ) , and amoxicillin/clavulanic acid (21.1%), respectively. That of Enterococcus spp. were linezolid (0), glycopeptides (0. 4% - 5.1% ), fosfomycin (6. 7% - 17.2% ) and nitrofurantoin ( 6. 6% - 47.9% ) , respectively. Conclusion E. coli remains the urinary tract infection major pathogen but the proportion of Enterococci was significantly increased.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2011年第12期913-918,共6页 The Chinese Journal of Clinical Pharmacology
关键词 泌尿系统感染 细菌耐药监测 urinary tract infection bacterial resistance surveillance
  • 相关文献

参考文献2

二级参考文献8

共引文献72

同被引文献51

  • 1郑波,王珊,李耘,薛峰,肖永红.万古霉素耐药肠球菌基因及水平转移研究[J].中国临床药理学杂志,2007,23(2):133-136. 被引量:10
  • 2陈靖,林善炎.尿路感染.见:陈灏珠,主编.实用内科学.13版,北京:人民卫生出版社.2009:2339-2345.
  • 3Clinical and Laboratory Standard Institute. Performance standards for antimierobial susceptibility testing; nineteenth informational supple- ment. Wayne: Clincial and Laboratory Standards Institute. 2012.
  • 4Grabe M, Bjerklund -johansen T E, Botto H, et al. Guidelines on urological infections [ EB/OL ]. http://www, guide, medlive, en/ guideline/2085, 2011 - 03 - 21.
  • 5Gobernado M. Fosfomicina[ J]. Rev Esp Quimioterap, Marzo, 2003; 16:15 -40.
  • 6Falagas ME, Kastoris AC, Kapaskelis AM, et al. Fosfomycin for the treatment of muhidrug - resistant, including extended - spectrum beta -lactamase producing, Enterobacteriaceae infections: a systematic review [ J ]. Lancet Infect Dis, 2011 ; 10:43 - 50.
  • 7Nicolle L. Urinary tract infection long- term care facility resi- dents. Clin Infect Dis ,2000,31 (3) :757 - 759.
  • 8Nicolle LE ,Bradley S ,Colgan R,et al. Infection Diseases Society of American guidelines for the diagnosis and treatment of asymp- tomatic bacteriuria in adults. Clin Infect Dis, 2005,40 ( 5 ) : 643 - 646.
  • 9Rafailidis PI, Ioannidou EN, Falagas ME. Ampicillin/sulbactam: current status in severe bacterial infections[J]. Drugs, 2007,67 (13) : 1829-1849.
  • 10Clinical and laboratory standard institute. Performance standards for antimicrobial susceptibility testing,nineteenth informational supplement[S].Wayne:Clincial and Laboratory Standards institute,2013.

引证文献9

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部